You are here

EASD Rising Star Symposium & EFSD Research Fellowship

Supported by Novo Nordisk

2017

Gustaf Christoffersson: Uppsala University - Sweden
Harnessing the immunosuppressive effects of the non-autoreactive islet infiltrate in type 1 diabetes

Teresa Mezza: Catholic University of the Sacred Heart - Rome, Italy
Investigating the role of intra-islet GLP-1 production in the modulation of islet plasticity in humans

Andrew Wood: University of Exeter - UK
Using genetics to understand the interaction between BMI and physical activity and risk of obesity and type 2 diabetes

Hanieh Yaghootkar: University of Exeter - UK
Using human genetics to understand the underlying mechanisms that protect some obese people from type 2 diabetes

2016

Francesca D'Addio: San Raffaele Scientific Institute - Milan, Italy
Overriding the regulatory beta cell defect in type 1 diabetes 

Angus Jones: University of Exeter - UK
Using a genetic risk score to identify patients with type 1 diabetes who will require early insulin therapy

Sander Kooijman: Leiden University - The Netherlands
Time to heat up: targeting circadian rhythms in brown fat to combat diabetes

Niina Sandholm: Folkhälsan Research Center - Helsinki, Finland
Dissection of genetic background of diabetic nephropathy in subjects with type 1 diabetes

2015

Martin Heni: University Hospital Tübingen - Germany
Effect of brain insulin action on pancreatic insulin secretion in humans

David Hodson: Imperial College London - UK
Optical control of beta cell function using a GLP-1R photoswitch

Ruben Nogueiras: University of Santiago de Compostela - Spain
Role of p53 on hepatic steatosis and insulin sensitivity

Robert Scott: University of Cambridge - UK
Novel insights into the role of adipogenesis in the aetiology of insulin resistance: a multidisciplinary approach

2014

Gijs H Goossens: Maastricht University - The Netherlands
Targeting adipose tissue oxygen tension to improve insulin sensitivity in humans

Hiddo Jan Lambers Heerspink: Uni Medical Center - Groningen, The Netherlands
A new approach for personalised medicine in type 2 diabetes: integrating multiple effects of a single drug

Lorenzo Pasquali: FCRB - Barcelona, Spain
Identification of type 2 diabetes target genes

Rinke Stienstra: Radboud University - Nijmegen, The Netherlands
A shift in macrophage metabolism drives obesity-induced inflammation and the development of insulin resistance